EMS-CHEMIE HOLDING AG

Latest Results (17.12.2024):

Net Sales and Income

In the first half of 2024, EMS-CHEMIE HOLDING AG reported net sales of CHF 1,087 million, a decrease from CHF 1,183 million in the previous year. Despite the stronger Swiss Franc impacting sales, the company achieved a net operating income of CHF 291 million, up from CHF 280 million in the first half of 2023. This increase was attributed to successful new business initiatives launched in 2023.

Market Environment and Strategy

EMS-CHEMIE HOLDING AG faced a challenging market environment in the first half of 2024, with weak global economic development and low consumer confidence in key markets like Europe and China. Despite these challenges, the company focused on expanding its market presence and developing innovative solutions, particularly in high-demand areas such as electric vehicles and healthcare.

Profit Margins and Financial Performance

The company reported an EBIT margin of 26.8% and an EBITDA margin of 29.4% for the first half of 2024, both showing improvement from the previous year. Net income increased by 2.1% to CHF 252 million, reflecting the company's strong position in specialty products and innovations despite unfavorable currency conditions.

Equity and Financial Position

EMS-CHEMIE HOLDING AG's equity attributable to shareholders rose to CHF 1,998 million as of June 30, 2024, up from CHF 1,742 million at the end of 2023. The equity ratio improved to 82.7%, indicating a robust financial position and increased shareholder value.

Outlook for 2024

Looking ahead, EMS-CHEMIE HOLDING AG anticipates a continued challenging economic environment for the remainder of 2024. The company expects net sales to be slightly below the previous year due to currency effects, but projects net operating income to be slightly above last year's figures. EMS plans to continue its growth strategy by investing in capacity and energy efficiency improvements, particularly at its main site in Switzerland.